Medication info
Dunab Tablet 60/2.5 mg (Pimasartan Potassium, Amlodipine)

Dunab Tablet 60/2.5 mg (Pimasartan Potassium, Amlodipine)

Prescription medicationTabletOral
Ingredient · strength
S-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletFimasartan Potassium Trihydrate›66.01mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharm Co., Ltd.
Appearance
Yellow, round-edged, rectangular film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 202204667 · Approved 2022.12.27 · Insurance code 649105680

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Korea Hutech Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used for patients with essential hypertension and may require additional treatment if blood pressure is not adequately controlled with monotherapy. This medication lowers blood pressure and relieves the burden on the heart and blood vessels. It acts as an adjunctive treatment when blood pressure management is not sufficient. It contributes to safe and effective blood pressure control, assisting in the overall blood pressure management of patients. It is used for the treatment of essential hypertension.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; discontinue immediately if pregnancy is confirmed. Patients with allergies to the ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with moderate to severe liver dysfunction, patients with bile duct obstruction, and those with certain kidney dysfunctions or diabetic nephropathy should not take this medication. Patients with reduced blood volume or low sodium, patients with impaired kidney function, renal artery hypertension, aortic stenosis, severe hypotension, and elderly patients should use this medication with caution. While taking this medication, side effects such as dizziness, headache, facial or peripheral edema, urinary disorders, insomnia, and flushing may occur, and one should consult a doctor if symptoms are severe. Symptoms of hypotension or electrolyte imbalance, especially hyperkalemia, may occur, so regular blood tests are important. Drowsiness or dizziness may occur while taking this medication, so caution should be exercised when driving or operating dangerous machinery. Interactions may occur if taken with other antihypertensives or diuretics, potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs, so it is essential to consult with a doctor or pharmacist. Pregnant or breastfeeding women should consult with healthcare professionals before taking this medication, particularly during pregnancy where avoidance is safest. It is not recommended for children under 18 years old as the safety and effectiveness of this medication have not been established in this age group. In case of overdose, symptoms such as severe hypotension or arrhythmias may occur, and immediate medical attention is required.

Side effects

  • dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disturbance
  • insomnia
  • flushing
  • syncope
  • sedation
Show 130 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • epigastric pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle spasms
  • musculoskeletal rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • cerebral infarction
  • fracture
  • chest pain
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • increased tension
  • sensory impairment
  • paresthesia
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, to maintain the medication's efficacy, it should be stored at a temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Yellow, round-edged, rectangular film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.